MYCN and EGFR can be amplified in double minutes in neuroblastoma and breast carcinomas, respectively, raising the possibility that KRAS G12C amplifications may arise in a similar way in NSCLC and CRC [104,105]. Here, EGFR is linked to non-small cell lung carcinoma.